JUSTIN MORGAN: Open Payments
NPI 1437389293 · MORGANTOWN, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 37 payments from 11 companies in 2025. Trend: 2023 $996 · 2024 $1,048 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $221 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $112 |
| PFIZER INC. | 4 | $78 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| GlaxoSmithKline, LLC. | 3 | $45 |
| ABBVIE INC. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Amgen Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: Kerendia, Wegovy, XIFAXAN, Ozempic, NURTEC ODT, TRELEGY ELLIPTA, Rybelsus, UBRELVY.
Industry payments across WV — which companies pay providers there.
